| 摘要 |
The invention relates to compositions for prevention or treatment of canine hip dysplasia. The use of human muscular dystrophy prophylactics or treatments in canine hip dysplasia, as well as other compositions comprising HDAC or myostatin inhibitors, muscle growth enhancers, anti-inflammatories, antioxidants, cross linking targets, alpha 7 integrin upregulators, steroids or antibiotics, and/or oxygenation proinflammatories is discussed. Also discussed are the potential gene mutations responsible for the symptoms of canine hip dysplasia and the targeting of the gene products as a preventative measure. |
